| GBM | glioblastoma |
| WHO | World Health Organization |
| TMZ | temozolomide |
| LTS | long-term survivor |
| NSC | neural stem cell |
| NPC | neural progenitor cell |
| SVZ | subventricular zone |
| PFS | progression-free survival |
| OS | overall survival |
| IDH1 | isocitrate dehydrogenase 1 |
| CEL | contrast-enhancing lesion |
| KPS | Karnofsky performance score |
| GTR | gross total resection |
| EOR | extent of resection |
| STS | short-term survivor |
| MGMT | O6-methylguanin-DNA-methyltransferase |
| CE | contrast-enhancing |
| T1-w | T1-weighted |
| FLAIR | fluid-attenuated inversion recovery |
| RT | radiotherapy |
| HR | hazard ratio |
| CI | confidence intervall |
| PACS | Picture Archiving and Communication System |
| RANO | Response Assessment in Neuro-Oncology |
| MPRAGE | magnetization-prepared rapid gradient-echo |